Impact of Ayuraksha Kit in COVID-19

Phase 3

• Registration Number: CTRI/2022/02/040156
• Lead Sponsor: Central council for research in Ayurvedic Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 February 2022

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

i.Participants not having COVID-19 like symptoms, of age between 18 â?? 70 years, of any sex from the identified scheduled castes predominant areas/villages across India

ii.Participants who are ready to provide informed consent.

iii.Participants who have been either vaccinated or not vaccinated shall be included in the study.

iv.Participants who have been taking any other prophylactic medicine other than Ayu Raksha kit for COVID -19 shall also be included. The details will be noted and data will be analysed accordingly

Exclusion Criteria

i.Participants presenting with COVID-19 like symptoms

ii.Participants diagnosed as case of COVID-19 by positive RT-PCR test within one month prior to inclusion.

iii.History of uncontrolled Diabetes mellitus or uncontrolled Hypertension

iv.Participants having any disease condition that would require immediate medical or surgical intervention

v.Known case of immune compromised state like HIV

vi.Known cases of COPD, Tuberculosis, Cancer, Hepatitis

vii.Participants on steroids or any immunosuppressive therapy

viii.Those who have participated in any other clinical trial within one month prior to screening

ix.Participants having a history of allergy to any medicine that is part of Ayu Raksha Kit

x.Women who are Pregnant or are planning for pregnancy during the study period or those who are lactating mothers

xi.The asymptomatic RT-PCR confirmed COVID-19 cases at the time of screening shall be excluded.

Study & Design

• Study Type: Interventional
• Study Design: Not specified